Clinical Trial Update: NGX-4010 for the Treatment of Postherpetic Neuralgia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trials of NGX-4010 (capsaicin patch 8%) for postherpetic neuralgia have completed, with status indicating completion of the studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster
• Postherpetic Neuralgia

Drugs mentioned

• NGX-4010 (capsaicin patch 8%)

Snippet

Sponsor: NeurogesX | Conditions: Herpes Zoster, Neuralgia | Phase 2, Phase 3 | Status: COMPLETED